New Novartis data show Cosentyx demonstrated sustained superiority in skin …

New Novartis data show Cosentyx demonstrated sustained superiority in skin …

… antagonist approved to treat adult patients with moderate to severe plaque psoriasis, with almost 15,000 U.S. patients prescribed to date.2 Cosentyx also was recently approved for the treatment of psoriatic arthritis and ankylosing spondylitis in

(Visited 1 times, 1 visits today)
3
Like
Save

Comments

Comments are disabled for this post.